Live Breaking News & Updates on Silence therapeutics

Stay updated with breaking news from Silence therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in Silence Therapeutics plc (NASDAQ:SLN) Rises By 74.8%

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, an increase of 74.8% from the March 15th total of 92,700 shares. Based on an average trading volume of 241,700 shares, the short-interest ratio […]

Nasdaq , Parkman-healthcare-partners , Goldman-sachs-group-inc , Silence-therapeutics-company-profile , Morgan-stanley , Vivo-capital , Silence-therapeutics , Get-free-report , Sachs-group , Healthcare-partners , Therapeutics-trading-down

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

Vipin-garg , Morgan-stanley , Drug-administration , Fortress-biotech , Journey-medical , New-drug-application , Prescription-drug-user-fee-act , Priority-review-vouchers , Silence-therapeutics , Chardan-capital ,

Extended Zerlasiran Data Show Sustained Lp(a) Reduction

The experimental siRNA agent led to prolonged Lp(a) reduction of more than 90%, extended data from the phase 1 trial show, supporting the move to phases 2 and 3 trials.

New-york , United-states , Cleveland , Ohio , Stevene-nissen , Roberts-rosenson , Icahn-school-of-medicine-at-mount-sinai , Cleveland-clinic , Silence-therapeutics , Icahn-school , Mount-sinai

Head to Head Survey: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)

Head to Head Survey: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , United-kingdom , London , City-of , Mallinckrodt-pharma , Ikaria-development , Hansoh-pharmaceutical-group-company , Bellerophon-therapeutics-inc , Silence-therapeutics , Get-free-report , Bellerophon-therapeutics

Head to Head Review: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)

Silence Therapeutics (OTCMKTS:SLNCF – Get Free Report) and Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 7.9% of Silence Therapeutics […]

New-jersey , United-states , London , City-of , United-kingdom , Mallinckrodt-pharma , Ikaria-development , Hansoh-pharmaceutical-group-company , Bellerophon-therapeutics-inc , Silence-therapeutics , Get-free-report , Bellerophon-therapeutics

London markets are broken and closed, says pharma boss

A British pharmaceuticals company has criticised London’s stock markets for being “completely broken and closed” after announcing plans to de-list and pursue a potential flotation in New York.

New-york , United-states , United-kingdom , Denmark , London , City-of , British , Danish , Ali-mortazavi , Wael-sawan , Redx-pharma , Twitter

London markets are broken and closed, says pharma boss

E-therapeutics joins the stampede of biotech companies quitting Aim

United-kingdom , New-york , United-states , London , City-of , Denmark , Danish , British , Wael-sawan , Ali-mortazavi , Redx-pharma , Shell

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)

Published findings demonstrate zerlasiran was well-tolerated and significantly reduced Lp after single and multiple dosing

...

United-states , American , Curtis-rambaran , Hansoh-pharma , Nasdaq , Journal-of-the-american-medical-association , Astrazeneca , Exchange-commission-on , Silence-therapeutics , American-medical-association , Chief-medical-officer , Securities-litigation-reform-act

Silence Therapeutics (SLN) Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein

Silence Therapeutics (SLN) Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Curtis-rambaran , Journal-of-the-american-medical-association , Nasdaq , Silence-therapeutics , American-medical-association , Chief-medical-officer ,

Web app can help patients determine if they qualify for a statin without a prescription

Web app can help patients determine if they qualify for a statin without a prescription
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Thomasm-maddox , Patricia-dickey , Eli-lilly , Himabindu-vidula , Stevene-nissen , Astrazeneca , Hospital-of-the-university-pennsylvania , Novartis , Medtronic , Thoracic-institute